Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1993 Apr 15;291(Pt 2):369–374. doi: 10.1042/bj2910369

Beryllium competitively inhibits brain myo-inositol monophosphatase, but unlike lithium does not enhance agonist-induced inositol phosphate accumulation.

W S Faraci 1, S H Zorn 1, A V Bakker 1, E Jackson 1, K Pratt 1
PMCID: PMC1132534  PMID: 8387266

Abstract

Despite limiting side-effects, lithium is the drug of choice for the treatment of bipolar depression. Its action may be due, in part, to its ability to dampen phosphatidylinositol turnover by inhibiting myo-inositol monophosphatase. Beryllium has been identified as a potent inhibitor of partially purified myo-inositol monophosphatase isolated from rat brain (Ki = 150 nM), bovine brain (Ki = 35 nM), and from the human neuroblastoma cell line SK-N-SH (Ki = 85 nM). It is over three orders of magnitude more potent than LiCl (Ki = 0.5-1.2 mM). Kinetic analysis reveals that beryllium is a competitive inhibitor of myo-inositol monophosphatase, in contrast with lithium which is an uncompetitive inhibitor. Inhibition of exogenous [3H]inositol phosphate hydrolysis by beryllium (IC50 = 250-300 nM) was observed to the same maximal extent as that seen with lithium in permeabilized SK-N-SH cells, reflecting inhibition of cellular myo-inositol monophosphatase. However, in contrast with that observed with lithium, agonist-induced accumulation of inositol phosphate was not observed with beryllium in permeabilized and non-permeabilized SK-N-SH cells and in rat brain slices. Similar results were obtained in permeabilized SK-N-SH cells when GTP-gamma-S was used as an alternative stimulator of inositol phosphate accumulation. The disparity in the actions of beryllium and lithium suggest that either (1) selective inhibition of myo-inositol monophosphatase does not completely explain the action of lithium on the phosphatidylinositol cycle, or (2) that uncompetitive inhibition of myo-inositol monophosphatase is a necessary requirement to observe functional lithium mimetic activity.

Full text

PDF
369

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison J. H., Blisner M. E., Holland W. H., Hipps P. P., Sherman W. R. Increased brain myo-inositol 1-phosphate in lithium-treated rats. Biochem Biophys Res Commun. 1976 Jul 26;71(2):664–670. doi: 10.1016/0006-291x(76)90839-1. [DOI] [PubMed] [Google Scholar]
  2. Allison J. H., Stewart M. A. Reduced brain inositol in lithium-treated rats. Nat New Biol. 1971 Oct 27;233(43):267–268. doi: 10.1038/newbio233267a0. [DOI] [PubMed] [Google Scholar]
  3. Attwood P. V., Ducep J. B., Chanal M. C. Purification and properties of myo-inositol-1-phosphatase from bovine brain. Biochem J. 1988 Jul 15;253(2):387–394. doi: 10.1042/bj2530387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Avissar S., Schreiber G., Danon A., Belmaker R. H. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex. Nature. 1988 Feb 4;331(6155):440–442. doi: 10.1038/331440a0. [DOI] [PubMed] [Google Scholar]
  5. Berridge M. J. Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem. 1987;56:159–193. doi: 10.1146/annurev.bi.56.070187.001111. [DOI] [PubMed] [Google Scholar]
  6. Berridge M. J. The Albert Lasker Medical Awards. Inositol trisphosphate, calcium, lithium, and cell signaling. JAMA. 1989 Oct 6;262(13):1834–1841. [PubMed] [Google Scholar]
  7. Chen I. W., Charalampous C. F. Biochemical studies on inositol. IX. D-Inositol 1-phosphate as intermediate in the biosynthesis of inositol from glucose 6-phosphate, and characteristics of two reactions in this biosynthesis. J Biol Chem. 1966 May 25;241(10):2194–2199. [PubMed] [Google Scholar]
  8. Cleland W. W. Statistical analysis of enzyme kinetic data. Methods Enzymol. 1979;63:103–138. doi: 10.1016/0076-6879(79)63008-2. [DOI] [PubMed] [Google Scholar]
  9. Cornish-Bowden A. Why is uncompetitive inhibition so rare? A possible explanation, with implications for the design of drugs and pesticides. FEBS Lett. 1986 Jul 14;203(1):3–6. doi: 10.1016/0014-5793(86)81424-7. [DOI] [PubMed] [Google Scholar]
  10. Fisher S. K., Domask L. M., Roland R. M. Muscarinic receptor regulation of cytoplasmic Ca2+ concentrations in human SK-N-SH neuroblastoma cells: Ca2+ requirements for phospholipase C activation. Mol Pharmacol. 1989 Feb;35(2):195–204. [PubMed] [Google Scholar]
  11. Fisher S. K., Snider R. M. Differential receptor occupancy requirements for muscarinic cholinergic stimulation of inositol lipid hydrolysis in brain and in neuroblastomas. Mol Pharmacol. 1987 Jul;32(1):81–90. [PubMed] [Google Scholar]
  12. Ganzhorn A. J., Chanal M. C. Kinetic studies with myo-inositol monophosphatase from bovine brain. Biochemistry. 1990 Jun 26;29(25):6065–6071. doi: 10.1021/bi00477a026. [DOI] [PubMed] [Google Scholar]
  13. Gee N. S., Ragan C. I., Watling K. J., Aspley S., Jackson R. G., Reid G. G., Gani D., Shute J. K. The purification and properties of myo-inositol monophosphatase from bovine brain. Biochem J. 1988 Feb 1;249(3):883–889. doi: 10.1042/bj2490883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Godfrey P. P., McClue S. J., White A. M., Wood A. J., Grahame-Smith D. G. Subacute and chronic in vivo lithium treatment inhibits agonist- and sodium fluoride-stimulated inositol phosphate production in rat cortex. J Neurochem. 1989 Feb;52(2):498–506. doi: 10.1111/j.1471-4159.1989.tb09148.x. [DOI] [PubMed] [Google Scholar]
  15. Hallcher L. M., Sherman W. R. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J Biol Chem. 1980 Nov 25;255(22):10896–10901. [PubMed] [Google Scholar]
  16. Jackson R. G., Gee N. S., Ragan C. I. Modification of myo-inositol monophosphatase by the arginine-specific reagent phenylglyoxal. Biochem J. 1989 Dec 1;264(2):419–422. doi: 10.1042/bj2640419. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. KLEMPERER F. W. Interaction of beryllium with enzymes. Science. 1950 Oct 13;112(2911):423–423. [PubMed] [Google Scholar]
  18. Lanzetta P. A., Alvarez L. J., Reinach P. S., Candia O. A. An improved assay for nanomole amounts of inorganic phosphate. Anal Biochem. 1979 Nov 15;100(1):95–97. doi: 10.1016/0003-2697(79)90115-5. [DOI] [PubMed] [Google Scholar]
  19. Majerus P. W., Connolly T. M., Bansal V. S., Inhorn R. C., Ross T. S., Lips D. L. Inositol phosphates: synthesis and degradation. J Biol Chem. 1988 Mar 5;263(7):3051–3054. [PubMed] [Google Scholar]
  20. Sherman W. R., Gish B. G., Honchar M. P., Munsell L. Y. Effects of lithium on phosphoinositide metabolism in vivo. Fed Proc. 1986 Oct;45(11):2639–2646. [PubMed] [Google Scholar]
  21. Sherman W. R., Munsell L. Y., Gish B. G., Honchar M. P. Effects of systemically administered lithium on phosphoinositide metabolism in rat brain, kidney, and testis. J Neurochem. 1985 Mar;44(3):798–807. doi: 10.1111/j.1471-4159.1985.tb12886.x. [DOI] [PubMed] [Google Scholar]
  22. Takimoto K., Okada M., Matsuda Y., Nakagawa H. Purification and properties of myo-inositol-1-phosphatase from rat brain. J Biochem. 1985 Aug;98(2):363–370. doi: 10.1093/oxfordjournals.jbchem.a135290. [DOI] [PubMed] [Google Scholar]
  23. Zorn S. H., Duman R. S., Giachetti A., Micheletti R., Giraldo E., Krogsgaard-Larsen P., Enna S. J. (R)-nipecotic acid ethyl ester: a direct-acting cholinergic agonist that displays greater efficacy at M2 than at M1 muscarinic receptors. J Pharmacol Exp Ther. 1987 Jul;242(1):173–178. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES